The concomitant usage of buprenorphine and CYP3A4 inducers can lessen the plasma concentration of buprenorphine [see CLINICAL PHARMACOLOGY], perhaps leading to decreased efficacy or onset of a withdrawal syndrome in people who have created physical dependence to buprenorphine.Buprenorphine features a number of Rewards to Individuals with OUD and al